Marcks Erbitux may be on sale by end of year
Erbitux, the controversial new cancer treatment, could be on the market by the end of the year after Merck, the German pharmaceuticals group, said it had applied to Swiss and European Union
Erbitux, the controversial new cancer treatment, could be on the market by the end of the year after Merck, the German pharmaceuticals group, said it had applied to Swiss and European Union